Physician profile
William C Moore
NPI 1891736138
$6,130.22
in general payments reported to CMS, 2019-2025
34 companies · $88.33 in 2025
The $88.33 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,343 · 2020: $1,487 · 2021: $2,231 · 2022: $721 · 2023: $108 · 2024: $152 · 2025: $88.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $348.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $348.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $3,285.92 | 2019-2025 | Octrode |
| Medtronic, INC. | $317.83 | 2021 | |
| Collegium Pharmaceutical, INC. | $311.89 | 2019-2023 | Belbuca |
| Boston Scientific Corporation | $280.07 | 2020-2025 | Wavewriter Alpha Prime 16 |
| Nevro Corp. | $245.26 | 2019-2020 | |
| Vertiflex, INC. | $201.85 | 2019 | |
| Medtronic USA, INC. | $149.80 | 2019-2020 | |
| Pfizer INC. | $124.63 | 2020-2021 | |
| Almatica Pharma LLC | $110.61 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $108.62 | 2019 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Spinal Simplicity, LLC | $87.59 | 2020-2023 | Ha Minuteman G3-R |
| Virtus Pharmaceuticals LLC | $69.85 | 2021 | |
| Biodelivery Sciences International, INC. | $66.85 | 2020 | |
| Nalu Medical, INC. | $61.07 | 2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fidia Pharma USA INC. | $60.59 | 2022-2023 | Hymovis, Triluron |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $60.36 | 2020 | |
| Dexcom, INC. | $58.22 | 2024-2025 | Dexcom G6 Transmitter |
| Genesys Orthopedics Systems, L.L.C. | $57.80 | 2022 | |
| Ibsa Pharma INC. | $49.50 | 2021 | |
| Vertos Medical, INC. | $45.09 | 2021 | |
| Arbor Pharmaceuticals, INC. | $44.32 | 2019-2021 | |
| Daiichi Sankyo INC. | $35.22 | 2019 | |
| Zyla Life Sciences, INC. | $29.57 | 2020 | |
| Stryker Corporation | $26.86 | 2019 | |
| Baudax Bio INC. | $26.13 | 2020 | |
| Lundbeck LLC | $19.71 | 2023 | Vyepti |
| Novartis Pharmaceuticals Corporation | $17.32 | 2021 | |
| Mdd US Operations, LLC | $15.40 | 2019 | |
| Forte Bio-Pharma LLC | $14.50 | 2021 | |
| Stimwave Technologies Incorporated | $13.81 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $13.47 | 2021 | |
| Astrazeneca Pharmaceuticals Lp | $11.39 | 2019 | |
| Horizon Therapeutics Plc | $11.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.